Cannabis Related Content

Menopause symptoms, ranging from hot flashes to weight gain, can be eased with cannabis and CBD, research finds.

America is gripped by opioid addiction and a dangerous opioid epidemic - could CBD be a viable replacement?

Savage Cabbage Ltd give insight into the UK CBD market, defining the differences in cannabinoid products and their roles in the industry.

Cannabis legislation is threatening to reduce pharmaceutical stock value by billions of dollars as more people are predicted to opt for weed over opioids.

Senior Associate David Hardstaff and Partner John Binns of BCL Solicitors LLP, share their views on a blueprint for the UK Cannabis Industry.

Medical cannabis remains difficult to attain in healthcare under the British government, but it holds great promise for both NHS patients and the economy.

Countries all over the world are debating whether to legalise cannabis; but what really happens when the recreational drug is made legal?

Cannabidiol, more commonly known as CBD, may halve the severity of symptoms and impairment caused by chronic anxiety.

Cannabinoids with high THC-to-CBD ratios can help to improve moderate, short-term chronic pain band may be an alternative to opioids.

Emergency department attendance and instances requiring hospitalisations are 22% higher among cannabis users compared with those who do not.

Here, Savage Cabbage explain why their full-spectrum Cannabidiol (CBD) products are different to others on the market.

Dr Stephen Barnhill M.D from Apollon Formularies Plc discusses the potential for technology to upgrade personalised medicine for cannabis treatments.

Nick Morland, Tenacious Labs CEO, All-Party Parliamentary Group for CBD Products Secretariat, Jersey Cannabis Services Advisory Board Chair, writes about the UK Cannabis Industry – could this be the next Scottish Whisky?

Research finds that labels on weed often fail to adequately reflect products' chemical make-up and components of the weed strain.

One million homes will be given cannabis plants across Thailand, to mark the legalisation and attract foreign tourists – to be used for ‘medicinal purposes’ only.

Senior Associate David Hardstaff and Partner John Binns of BCL Solicitors explore shifting sands in the UK CBD industry.

Recreational and medicinal legalised marijuana can reduce demand for prescription drugs, via state Medicaid programmes.

Dr Stephen Barnhill MD, CEO of Apollon Formularies Plc, examines medical cannabis and the future of cancer treatments across the UK and the European healthcare sectors.

Suzette Smiley-Jewell, PhD & Pamela J. Lein, PhD from the University of California, Davis, explore the extent to which animal CBD products are safe

Prof Trevor M Jones charts the priorities for research and development, production and distribution of medical cannabis-based treatments